Analyst Ratings for [MRTX] Mirati Therapeutics, Inc.

8/10/23	Upgrades	Neutral Buy	X
MRTX Mirati Therapeutics Citigroup
$51 $48
8/9/23	Upgrades	Neutral Buy	X
MRTX Mirati Therapeutics B. Riley Securities
$45
8/9/23	Resumed	Overweight	X
MRTX Mirati Therapeutics Piper Sandler
$45
7/27/23	Initiated	Sector Underperform	X
MRTX Mirati Therapeutics Scotiabank
5/25/23	Upgrades	Perform Outperform	X
MRTX Mirati Therapeutics Oppenheimer
12/14/22	Initiated	Hold	X
MRTX Mirati Therapeutics Needham
12/9/22	Downgrades	Buy Neutral	X
MRTX Mirati Therapeutics Citigroup
$121 $53
12/8/22	Downgrades	Outperform Mkt Perform	X
MRTX Mirati Therapeutics BMO Capital Markets
$110 $59
12/8/22	Downgrades	Overweight Neutral	X
MRTX Mirati Therapeutics JP Morgan
$94 $65
10/28/22	Initiated	Neutral	X
MRTX Mirati Therapeutics B. Riley Securities
$72
9/15/22	Initiated	Overweight	X
MRTX Mirati Therapeutics Piper Sandler
$110
6/7/22	Upgrades	Mkt Perform Mkt Outperform	X
MRTX Mirati Therapeutics JMP Securities
$72
5/20/22	Upgrades	Neutral Buy	X
MRTX Mirati Therapeutics Guggenheim
$115
2/1/22	Upgrades	Underperform Neutral	X
MRTX Mirati Therapeutics BofA Securities
$171 $141
11/19/21	Initiated	Outperform	X
MRTX Mirati Therapeutics BMO Capital Markets
$187
6/4/21	Upgrades	Neutral Buy	X
MRTX Mirati Therapeutics Citigroup
5/17/21	Downgrades	Outperform Perform	X
MRTX Mirati Therapeutics Oppenheimer
5/10/21	Upgrades	Hold Buy	X
MRTX Mirati Therapeutics Jefferies
$208 $196
4/26/21	Resumed	Outperform	X
MRTX Mirati Therapeutics Credit Suisse
$285
8/2/19	Downgrades	Neutral Underweight	X
MRTX Mirati Therapeutics JP Morgan
$85
7/18/19	Initiated	Hold	X
MRTX Mirati Therapeutics Deutsche Bank
$86
6/19/19	Downgrades	Buy Neutral	X
MRTX Mirati Therapeutics B. Riley FBR
$60 $92
6/7/19	Downgrades	Buy Neutral	X
MRTX Mirati Therapeutics Guggenheim
6/5/19	Reiterated	Buy	X
MRTX Mirati Therapeutics H.C. Wainwright
$84 $117
6/4/19	Upgrades	Neutral Buy	X
MRTX Mirati Therapeutics Citigroup
$76 $132
4/17/19	Initiated	Neutral	X
MRTX Mirati Therapeutics JP Morgan
$72
3/25/19	Initiated	Outperform	X
MRTX Mirati Therapeutics Credit Suisse
$85
3/4/19	Downgrades	Buy Neutral	X
MRTX Mirati Therapeutics Citigroup
$64 $77
2/15/19	Initiated	Overweight	X
MRTX Mirati Therapeutics Piper Jaffray
$85
12/3/18	Initiated	Buy	X
MRTX Mirati Therapeutics B. Riley FBR
$60
10/29/18	Upgrades	Neutral Buy	X
MRTX Mirati Therapeutics Guggenheim
7/9/18	Reiterated	Outperform	X
MRTX Mirati Therapeutics Oppenheimer
$35 $62
3/12/18	Initiated	Overweight	X
MRTX Mirati Therapeutics Barclays
$44

MRTX Mirati Therapeutics, Inc.

Quotes: Barrons • SeekingAlpha • NASDAQ • Bloomberg • WSJ